Specifically, immune checkpoint inhibitors, such as PD-1/PD-L1 inhibitors, reinstate the immune system’s capacity to identify tumors by obstructing the pathways utilized by tumor cells to evade immune surveillance. The gene discussed is CD274; the disease is neoplasm.